|
|
77 Great Valley Parkway
Malvern, PA 19355 USA
phone:(610) 640-1775
fax:(610) 640-2603
|
|
| Symbol |
VITA |
| Exchange |
Nasdaq |
| Founded |
1992 |
| Employees |
114 |
|
|
| www.orthovita.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Synthetic tissue products for use in orthopedic and neurosurgical markets, including use for spine surgery and repair of osteoporotic fractures |
|
| Management |
| Antony Koblish, President and Chief Executive Officer; Nancy C. Broadbent, Senior Vice President and Chief Financial Officer; Maarten Persenaire, M.D., Chief Medical Officer; Christopher H. Smith, Senior Vice President, Sales and Marketing; William E. Tidmore, Jr., Director |
| |
|
|
|
|
|
|
| Recent Results |
| Product sales for the second quarter ended June 2006 increased 32% to $11.2 million. The VITOSS Foam platform accounted for 61% of sales, with VITAGEL maiking up 17% of sales for the quarter. The net loss for the quarter was $$5.46 million compared to a loss of $2.7 million in 2005. |
| |
|
|
|
|
| Keywords |
| orthobiologics, biosurgery, hemostasis, biosurgery, regeneration |
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members